Northwest Biotherapeutics | NWBO - Net Income


Northwest Biotherapeutics reported $-19.37M in Net Income for its fiscal quarter ending in September of 2024.





Net Income Change Date
Agenus USD -25.27M 20.59M Mar/2025
AstraZeneca USD 2.33B 207M Dec/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Celldex Therapeutics USD -67.04M 10.44M Sep/2025
Eisai JPY 17.18B 7.02B Dec/2025
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
Merck USD 2.96B 2.82B Dec/2025
Northwest Biotherapeutics USD -19.37M 1.5M Sep/2024
Pfizer USD -1.65B 5.19B Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025